HIGHLIGHTS
SUMMARY
Outcomes Measures included but not limited to: headache/migraine days, headache-related quality of life including Headache Impact Test 6 (HIT-6), Migraine Disability Assessment Score (MIDAS), and migraine specific quality of life, acute treatment use, headache intensity and duration, health service activity, days lost from usual activities, incremental cost-effectiveness ratios (ICER) (e_g, cost per disability-adjusted life year averted, cost per quality-adjusted life year gained). All studies originated from high-income countries, mainly countries in European Union (n=5), including two each in the UK and the United_States. Four reports were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.